Building Biotechs
0 FOLLOWERS
From the ground floor to the C-Suite, Building Biotechs offers a behind-the-scenes look into the strategy that goes into launching and scaling successful biotech and life science companies.
We talk with biotech executives, founders, HR leaders, and culture builders to learn how they think about growing companies with intention, and discuss the valuable lessons they've learned along the way.
Building Biotechs
3d ago
This week, we had a conversation with Catharine Smith - the Executive Director at the Termeer Foundation. Catharine is passionate about supporting biotech founders in growing patient-centric companies. We are thrilled about the Termeer Foundation and have been delighted to witness the Termeer Fellows thrive through the support, training, and community that this organization provides. If you're interested in making a difference in human health through biotech, this episode is definitely for you.
Link In with Catherine
The Termeer Foundation
Connect with us!
Link In with Carina
Link In with A ..read more
Building Biotechs
1w ago
In this episode, we chatted with Isaac Stoner, M.B.A., the CEO of Octagon Therapeutics. Isaac is known for his expertise in building small companies and embarking on adventurous missions such as recovering airplane black boxes (yes, you read that correctly!). He also hosts a science enthusiast networking group in Cambridge, where attendees drink beer and discuss science.
Linkedin
Octagon Therapeutics
Connect with us!
Link In with Carina
Link In with Alison
Check out our three most downloaded episodes:
Applying the Flagship “What If” Approach to Talent Acquisition With Leslie Martin, VP of ..read more
Building Biotechs
1w ago
This week we sat down with Kyriakos Economides, PhD, VP of Translational Pharmacology at Werewolf Therapeutics. If there’s one constant in biotech, it’s change. We discussed the evolution of a career, rolling with the punches, and the importance of a solid clinical plan early in the drug development lifecycle.
Werewolf Therapeutics Inc.
Linked In with Kyriakos
Connect with us!
Link In with Carina
Link In with Alison
Check out our three most downloaded episodes:
Applying the Flagship “What If” Approach to Talent Acquisition With Leslie Martin, VP of Talent Acquisition at Flagshi ..read more
Building Biotechs
2w ago
This week we sat down with Kyriakos Economides, PhD, VP of Translational Pharmacology at Werewolf Therapeutics. If there’s one constant in biotech, it’s change. We discussed the evolution of a career, rolling with the punches, and the importance of a solid clinical plan early in the drug development lifecycle.
Werewolf Therapeutics Inc.
Linked In with Kyriakos
Connect with us!
Link In with Carina
Link In with Alison
Check out our three most downloaded episodes:
Applying the Flagship “What If” Approach to Talent Acquisition With Leslie Martin, VP of Talent Acquisition at Flagshi ..read more
Building Biotechs
3w ago
This week, we had an insightful conversation with Leen Kawas, PhD, Managing General Partner at Propel Bio Partners. She shared her journey from studying pharmacy to founding a successful company (with a great exit) and now running a venture fund. She emphasizes the business case for the importance of DEI in the company leadership and in clinical trials. We also touched on tips on managing conflict in teams, fostering healthy communication, and the value of building a strong network and connections in the industry.
Propel Bio Partners
Link in with Leen!
Connect with us!
Link In with Carina
L ..read more
Building Biotechs
1M ago
This week, we had the pleasure of chatting with Andrew Fraley, PhD, Entrepreneur in Residence with Atlas Venture. We chatted about his journey from bench chemist to entrepreneur, and some of the things he learned in the process. He also shared valuable insights on structuring a pitch deck for those on the funding trail. Tune in to learn from Andrew's fascinating experiences and fantastic advice!
Atlas Venture - We build breakthrough biotechnology companies.
Link In with Andrew!
Connect with us!
Link In with Carina
Link In with Alison
Check out our three most downloaded episodes:
Applying t ..read more
Building Biotechs
1M ago
In this episode, Rikin Mehta, Pharm.D., J.D., LL.M. co-founder of Lactiga and co-founder and CEO of Licentiam, discusses the importance of looking at biotech through a regulatory lens. Rik shares insights on the significance of regulatory knowledge across an organization and reflects on how his diverse career journey helped shape his outlook on building solid companies. He shares how regulatory knowledge plays a vital role in every aspect of the organization, and how you can apply that knowledge to your company.
Licentiam
Lactiga
Link In with Rik!
Connect with us!
Link In with Carina
Link I ..read more
Building Biotechs
1M ago
In this episode, John Doyle, PhD, Education Director at the Gloucester Biotechnology Academy, discusses the valuable opportunities the Academy offers for biotech companies through its internship program. He highlights how the program impacts the science workforce and provides insights into their curriculum, which trains students for professional careers in biotech and life science labs. Tune in to learn more about how the Academy supports and prepares students for success in the biotechnology industry.
Gloucester Marine Genomics Institute
Link In with John!
Connect with us!
Link In with Car ..read more
Building Biotechs
1M ago
In this episode, we chatted with Bruce Wu, Chief Legal Officer and Corporate Secretary at Deep Cell, a biotech pioneering new methods in single-cell analysis by combining innovations in microfluidics, optics, and AI. Bruce's diverse background in engineering and law has led him to his current role, where he continues to combine his love for helping others, solving puzzles, and building innovative companies.
Deepcell
Link In With Bruce!
Connect with us!
Link In with Carina
Link In with Alison
Check out our three most downloaded episodes:
Applying the Flagship “What If” Approach to Talent Ac ..read more
Building Biotechs
1M ago
This week, we sat down with Tania Philipp, Chief People Officer at Vor Bio. Vor’s mission is to cure blood cancers through cell and genome engineering. Tania shares insights from rapid growth, hiring for culture during a pandemic, and taking a company public while maintaining culture and transparency.
Vor Bio | Cell & Genome Engineering Biotechnology Company
Link In with Tania
Connect with us!
Link In with Carina
Link In with Alison
Check out our three most downloaded episodes:
Applying the Flagship “What If” Approach to Talent Acquisition With Leslie Martin, VP of Talent Acquisition a ..read more